Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03637452 · ClinicalTrials.gov registry record

Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability

A clinical trial of Tobacco Use, sponsored by University of Oklahoma.

Completed
Registry status
19
Enrollment target
1
Study location

NCT03637452 is a study of Tobacco Use that has completed, run by University of Oklahoma. The registered enrollment target is 19 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03637452, a study of Tobacco Use, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
19 participants
Enrollment target
1
Study location

Study Summary

The overall aim of the current research is to understand purchasing and product choice behaviors of tobacco/nicotine users if banning the sale of fully nicotinized cigarettes were to go into effect. A sample of up to 30 current cigarette users (n=15) and dual e-cigarette and combustible cigarette users (n=15) who are willing to try an alternative nicotine-delivery device will be recruited. They will complete the screening visit, visit 1 and 2 preceded by 12 hours of nicotine/tobacco abstinent.

Conditions Studied

Study Locations (1)

Oklahoma

  • University of Oklahoma Health Sciences Center Tobacco Research Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-11-12
Est. Completion 2019-05-23

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT03637452

The ClinicalTrials.gov registry entry for NCT03637452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (95% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 0 interventions.

NCT03637452 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03637452 about?

NCT03637452 is a clinical study titled "Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability". The overall aim of the current research is to understand purchasing and product choice behaviors of tobacco/nicotine users if banning the sale of fully nicotinized cigarettes were to go into effect. A sample of up to 30 current cigarette users (n=15) and dual e-cigarette and combustible cigarette us...

What is the current status of trial NCT03637452?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2018-11-12. Estimated completion is 2019-05-23.

What conditions does trial NCT03637452 study?

This clinical trial studies the following conditions: Tobacco Use.

Who is sponsoring clinical trial NCT03637452?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03637452 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.